Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma
Conclusions:
Overall, patients with IHHE do well, a significant percentage of whom do not require drug therapy, particularly for those with small focal lesions. In patients with multifocal/diffuse disease, there is a high incidence of low T3 and T4 and while some of these patients did well without additional therapy, those with rapidly progressive lesions during treatment may do poorly.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Children | Egypt Health | Hemangioendothelioma | Hematology | Inderal | Pediatrics | Prednisolone